Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
21/04/2026 07:07
April 21 (Reuters) - Elicera Therapeutics AB ELIC.ST: Q1 ADJUSTED EPS SEK -0.1 Q1 OPERATING LOSS AMOUNTED TO SEK -5,116,779 Q1 LOSS FOR PERIOD AMOUNTED TO SEK -5,060,060 Source text: ID:nWkr6vCtlJ Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application